Chatbot vs. counselor: can AI help rural patients get cancer genetic testing?

NCT ID NCT06089421

Recruiting now Knowledge-focused Sponsor: University of Virginia Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study compares two ways to provide pre-test genetic counseling to people at high risk for hereditary cancers: a chatbot (Genetic Information Assistant) versus a live telegenetics session with a genetic counselor. About 96 participants will be randomly assigned to one method, then offered genetic testing. Researchers want to see if the chatbot is as effective as a counselor in helping people decide whether to get tested, with the goal of expanding access in rural areas.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Genetic Information Assistant (chatbot) and telegenetics counseling
What this could lead to: If successful, this could show that a chatbot is a practical, low-cost way to provide genetic education, making cancer screening more accessible in rural communities.
What could go wrong: This is a small, early-stage feasibility study (96 participants) comparing two counseling methods, not testing a new treatment. The chatbot may not be as effective as a human counselor, and results may not apply to all populations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GENE MUTATION-RELATED CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

inherited disease susceptibility

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GENE MUTATION-RELATED CANCER GENETIC PREDISPOSITION

Contacts and locations

Locations

University of Virginia
RECRUITING

Charlottesville, Virginia, 22930, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.